80 related articles for article (PubMed ID: 31780762)
1. Brain metastases in non-small-cell lung cancer: better outcomes through current therapies and utilization of molecularly targeted approaches.
Lukas RV; Lesniak MS; Salgia R
CNS Oncol; 2014 Jan; 3(1):61-75. PubMed ID: 25054901
[TBL] [Abstract][Full Text] [Related]
2. Chemoimmunotherapy for Untreated Lung Cancer Brain Metastases: A Reason for Optimism While Avoiding Overreaching Interpretations.
Lehrer EJ; Trifiletti DM; Fadul CE; Brown PD; Sheehan JP
J Clin Oncol; 2024 Mar; 42(7):857-858. PubMed ID: 38079583
[No Abstract] [Full Text] [Related]
3. Stereotactic radiosurgery with whole brain radiotherapy combined with bevacizumab in the treatment of brain metastases from NSCLC.
Li L; Feng M; Xu P; Wu YL; Yin J; Huang Y; Tan MY; Jinyi L
Int J Neurosci; 2023 Mar; 133(3):334-341. PubMed ID: 33843421
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of bevacizumab combined with chemotherapy in symptomatic brain metastases from lung adenocarcinoma: a retrospective analysis.
Zhan Q; Miao F; Huang R; Zhou X; Ge M; Liang X
J Thorac Dis; 2019 Nov; 11(11):4725-4734. PubMed ID: 31903262
[TBL] [Abstract][Full Text] [Related]
5. Lung Cancer with Brain Metastases Treated with Radiotherapy Followed by Bevacizumab Maintenance: A Case Report.
Khan SA; Gautam S; Sapkota S
JNMA J Nepal Med Assoc; 2022 Jun; 60(250):569-572. PubMed ID: 35690983
[TBL] [Abstract][Full Text] [Related]
6. Impact of Anti-angiogenic Drugs on Severity of COVID-19 in Patients with Non-Small Cell Lung Cancer.
Peng S; Huang H; Chen J; Ding X; Zhu X; Liu Y; Chen L; Lu Z
Technol Cancer Res Treat; 2024; 23():15330338241248573. PubMed ID: 38656242
[No Abstract] [Full Text] [Related]
7. Bevacizumab improved prognosis for advanced EGFR-mutant lung adenocarcinoma with brain metastasis receiving cerebral radiotherapy.
Zhou Y; Li J; Li Y; Deng G; Wang Q; Qin H; Li J; Li Z
Clin Transl Oncol; 2024 Mar; ():. PubMed ID: 38478262
[TBL] [Abstract][Full Text] [Related]
8. Management of brain metastasis from rectal cancer using whole‑brain radiation therapy followed by bevacizumab and chemotherapy: A case report.
Van Nguyen H; Phung DT; Nguyen TT; Tran BT; Thi Mai KN; Le Trinh H
Oncol Lett; 2023 Oct; 26(4):446. PubMed ID: 37720667
[TBL] [Abstract][Full Text] [Related]
9. Outcome benefits of bevacizumab biosimilar (SIBP04) combined with carboplatin and paclitaxel in advanced non-squamous non-small-cell lung cancer patients with EGFR mutation: subgroup analysis of a prospective, randomized phase III clinical trial.
Qu A; Zhang S; Zou H; Li S; Chen D; Zhang Y; Li S; Zhang H; Yang J; Yang Y; Huang Y; Li X; Zhang Y
J Cancer Res Clin Oncol; 2023 Nov; 149(14):12713-12721. PubMed ID: 37452849
[TBL] [Abstract][Full Text] [Related]
10. The Effect of the Kirsten Rat Sarcoma Viral Oncogene Homolog (
Song Z; Ren G; Wang X; Hu L
Genet Test Mol Biomarkers; 2022 May; 26(5):290-297. PubMed ID: 35638910
[No Abstract] [Full Text] [Related]
11. The different overall survival between single-agent EGFR-TKI treatment and with bevacizumab in non-small cell lung cancer patients with brain metastasis.
Chiu TH; Tung PH; Huang CH; Ju JS; Huang AC; Wang CC; Ko HW; Hsu PC; Fang YF; Guo YK; Kuo CS; Yang CT
Sci Rep; 2022 Mar; 12(1):4398. PubMed ID: 35292755
[TBL] [Abstract][Full Text] [Related]
12. Estrogen Promotes Resistance to Bevacizumab in Murine Models of NSCLC.
Patel SA; Herynk MH; Cascone T; Saigal B; Nilsson MB; Tran H; Ramachandran S; Diao L; Wang J; Le X; Minna J; Wistuba II; Heymach JV
J Thorac Oncol; 2021 Dec; 16(12):2051-2064. PubMed ID: 34311109
[TBL] [Abstract][Full Text] [Related]
13. Continuous Low-Dose Apatinib Combined With WBRT Significantly Reduces Peritumoral Edema and Enhances the Efficacy of Symptomatic Multiple Brain Metastases in NSCLC.
Ren Y; Wang SB; Zhou L; Liu SQ; Du LY; Li T; Jiang MQ; Lei KJ; Tan BX; Jia YM
Technol Cancer Res Treat; 2021; 20():15330338211011968. PubMed ID: 33955301
[TBL] [Abstract][Full Text] [Related]
14. Rational Application of First-Line EGFR-TKIs Combined with Antiangiogenic Inhibitors in Advanced EGFR-Mutant Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis.
Ma JT; Guo YJ; Song J; Sun L; Zhang SL; Huang LT; Jing W; Zhao JZ; Han CB
Biomed Res Int; 2021; 2021():8850256. PubMed ID: 33575349
[TBL] [Abstract][Full Text] [Related]
15. Bevacizumab for non-small cell lung cancer patients with brain metastasis: A meta-analysis.
Liang P; Wang YD; Wei ZM; Deng QJ; Xu T; Liu J; Luo N; Hou J
Open Med (Wars); 2020; 15(1):589-597. PubMed ID: 33313410
[TBL] [Abstract][Full Text] [Related]
16. Neuroinflammation After Stereotactic Radiosurgery-Induced Brain Tumor Disintegration Is Linked to Persistent Cognitive Decline in a Mouse Model of Metastatic Disease.
Chu C; Davis CM; Lan X; Hienz RD; Jablonska A; Thomas AM; Velarde E; Li S; Janowski M; Kai M; Walczak P
Int J Radiat Oncol Biol Phys; 2020 Nov; 108(3):745-757. PubMed ID: 32470502
[TBL] [Abstract][Full Text] [Related]
17. Blocking immunosuppressive neutrophils deters pY696-EZH2-driven brain metastases.
Zhang L; Yao J; Wei Y; Zhou Z; Li P; Qu J; Badu-Nkansah A; Yuan X; Huang YW; Fukumura K; Mao X; Chang WC; Saunus J; Lakhani S; Huse JT; Hung MC; Yu D
Sci Transl Med; 2020 May; 12(545):. PubMed ID: 32461334
[TBL] [Abstract][Full Text] [Related]
18. Bevacizumab for the treatment of non-small cell lung cancer patients with synchronous brain metastases.
Ascha MS; Wang JF; Kumthekar P; Sloan AE; Kruchko C; Barnholtz-Sloan JS
Sci Rep; 2019 Nov; 9(1):17792. PubMed ID: 31780762
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
